Article in Amyotrophic lateral sclerosis & frontotemporal degeneration, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors at 3 institutions in 1 country.
Waqar WaheedDepartment of Neurological Sciences, University of Vermont, University of Vermont Medical Center, Burlington, VT, USA.
Fatima KhanDepartment of Neurological Sciences, University of Vermont, University of Vermont Medical Center, Burlington, VT, USA.
Shelly NaudDepartment of Medical Biostatistics, University of Vermont, Burlington, VT, USA.
Edward KasarskisDepartment of Neurology, University of Kentucky, Lexington, KY, USA, and.
Dwight MatthewsDepartment of Chemistry, University of Vermont, Burlington, VT, USA.
Rup TandanDepartment of Neurological Sciences, University of Vermont, University of Vermont Medical Center, Burlington, VT, USA.
University of Vermont Medical Center · USUniversity of Kentucky · USUniversity of Vermont · US
Funding
WRITING AND THE DAILY EXPERIENCE OF ILLNESSM01RR010732 · NCRR · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LOHSE, BARBARA · 1995 to 2009
$29.8M
ZOLEDRONIC ACID IN PROSTATE CANCERM01RR000645 · NCRR · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI COLTEN, HARVEY R · 1985 to 2006
$27.0M
WEIGHT MAINTENANCE AND PSYCHOLOGICAL BENEFITS OF EXERCISEM01RR000109 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI KIRKPATRICK, BETH DIANE · 1985 to 2010
$24.3M
VIRAL DAMAGE TO BRAIN AND NEUROMUSCULAR SYSTEMM01RR000064 · NCRR · UNIVERSITY OF UTAH · PI LEPPERT, MARK · 1985 to 2008
$21.7M
XENOBIOTIC TRANSFER INTO MILK NITROFURANTOINM01RR002602 · NCRR · UNIVERSITY OF KENTUCKY · PI BLONDER, LEE XENAKIS · 1985 to 2007
$12.1M
Early Treatment of ALS with Nutrition and NIPPVR01NS045087 · NINDS · UNIVERSITY OF KENTUCKY · PI KASARSKIS, EDWARD JOSEPH · 2004 to 2007
$4.1M
GCRC RELOCATION AND EXPANSION PROJECTC06RR016499 · NCRR · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KIRCH, DARRELL G · 2001 to 2001
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Urine specific gravity to identify and predict hydration need in ALS. · full record | OpenQuestion